EUVIMEDDescubrir EUVIMED
Crossref

Gentiopicroside Ameliorates Psoriasis‐Like Dermatitis by Modulating Immune Homeostasis and Suppressing NF ‐ κB Activation

Lingyun Du, Xiaoke Zhao, Jingjing Wei, Shanrong Lv, Mingming Li iD, Yi Leng, Kemei Yu, Qingqing Xu iD, Chunhong Zhang iD

Phytotherapy Research · 2026-07 · 40 (7) · 4367-4383

DOI: 10.1002/ptr.70342 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-05-07. Written by Lingyun Du and 8 co-authors. Institution: Department of Dermato-Venereology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China. Major MEDLINE topics: Iridoid Glucosides, Psoriasis, NF-kappa B, Dermatitis. 44 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Psoriasis is a common chronic immune‐mediated inflammatory skin disease that presents significant challenges in clinical management. Gentiopicroside (GPS), a bioactive compound derived from Gentiana scabra , has been reported to possess anti‐inflammatory and immunomodulatory properties. However, its potential role in the treatment of psoriasis remains unclear. This study aimed to investigate the therapeutic effects of GPS on psoriasis‐like dermatitis and elucidate its underlying mechanisms. A psoriasis‐like dermatitis model was established in BALB/c mice using imiquimod (IMQ). The therapeutic efficacy of GPS was evaluated based on clinical and histopathological improvements. Flow cytometry was used to analyze immune cell populations in the spleen and peripheral blood. In vitro, the effects of GPS on bone marrow‐derived dendritic cells (BMDCs) were assessed in an inflammatory model. RNA sequencing was performed to identify differentially expressed genes and key signaling pathways in BMDCs after GPS treatment. Molecular docking was employed to predict the binding affinity between GPS and potential targets, which were further validated using Western blotting and immunofluorescence. GPS treatment significantly alleviated psoriasis‐like skin lesions in IMQ‐induced mice, improving both clinical manifestations and histopathological alterations. GPS reduced the proportions of lymphocytes and dendritic cells and attenuated Th17‐driven inflammation, thereby contributing to a more balanced immune milieu. In vitro, GPS inhibited the maturation and activation of BMDCs. Transcriptomic profiling demonstrated that GPS modulated multiple immune‐ and cytokine‐associated pathways, particularly the NF‐κB signaling pathway. Molecular docking suggested a strong binding affinity between GPS and NF‐κB p65, while Western blotting and immunofluorescence confirmed that GPS suppressed phosphorylated NF‐κB p65 nuclear translocation. GPS exerts anti‐psoriatic effects through multimodal mechanisms, including immunomodulation and suppression of NF‐κB activation. These findings provide experimental evidence and a theoretical basis for the development of GPS as a potential therapeutic agent for psoriasis.

Subjects

MeSH terms (MEDLINE)

Iridoid GlucosidesPsoriasisNF-kappa BDermatitisAnimalsMice, Inbred BALB CMiceDendritic CellsImiquimodMolecular Docking SimulationDisease Models, AnimalSignal TransductionHomeostasisMaleGentianaAnti-Inflammatory Agents

Author keywords

NF‐κBRNA sequencingdendritic cellsgentiopicrosidepsoriasis

Substances

Iridoid GlucosidesgentiopicrosideNF-kappa BImiquimodAnti-Inflammatory Agents

Authors and institutions

  • Department of Dermato-Venereology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Department of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Department of Dermatovenereology, Tianjin Medical University General Hospital, Tianjin, China.

ORCID profiles: Mingming Li, Qingqing Xu, Chunhong Zhang

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Cite

APA

Du, L., Zhao, X., Wei, J., Lv, S., Li, M., Leng, Y., Yu, K., Xu, Q., & Zhang, C. (2026). Gentiopicroside Ameliorates Psoriasis‐Like Dermatitis by Modulating Immune Homeostasis and Suppressing NF ‐ κB Activation. Phytotherapy Research, 40(7), 4367-4383. https://doi.org/10.1002/ptr.70342

Vancouver

Du L, Zhao X, Wei J, Lv S, Li M, Leng Y, et al. Gentiopicroside Ameliorates Psoriasis‐Like Dermatitis by Modulating Immune Homeostasis and Suppressing NF ‐ κB Activation. Phytotherapy Research. 2026;40(7):4367-4383. doi:10.1002/ptr.70342

BibTeX
@article{Du2026,
  author = {Du, Lingyun and Zhao, Xiaoke and Wei, Jingjing and Lv, Shanrong and Li, Mingming and Leng, Yi and Yu, Kemei and Xu, Qingqing and Zhang, Chunhong},
  title = {Gentiopicroside Ameliorates Psoriasis‐Like Dermatitis by Modulating Immune Homeostasis and Suppressing NF ‐ κB Activation},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {7},
  pages = {4367--4383},
  doi = {10.1002/ptr.70342}
}
Start for free →